Q32 Bio to Present at Oppenheimer Healthcare Conference Focusing on Immune Therapies Q32 Bio, a clinical stage biotechnology firm, is set to present its advancements in immune therapies at Oppenheimer's 35th Annual Healthcare Life Sciences Conference.

Q32 Bio to Present at Oppenheimer Healthcare Conference Focusing on Immune Therapies #USA #Healthcare_Conference #Q32_Bio #Waltham,_Massachusetts #Immune_Therapies